tiprankstipranks
Trending News
More News >
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
US Market

West Pharmaceutical Services (WST) Ratios

Compare
887 Followers

West Pharmaceutical Services Ratios

WST's free cash flow for Q4 2025 was $0.38. For the 2025 fiscal year, WST's free cash flow was decreased by $ and operating cash flow was $0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
3.02 3.02 2.79 2.88 3.70
Quick Ratio
2.34 2.34 2.11 2.24 2.90
Cash Ratio
1.21 1.21 0.88 1.27 1.72
Solvency Ratio
0.61 0.56 0.67 0.77 0.76
Operating Cash Flow Ratio
1.15 1.15 1.19 1.16 1.39
Short-Term Operating Cash Flow Coverage
0.00 33.25 34.76 5.79 329.09
Net Current Asset Value
$ 884.20M$ 884.20M$ 577.00M$ 987.90M$ 987.60M
Leverage Ratios
Debt-to-Assets Ratio
0.08 0.10 0.08 0.08 0.09
Debt-to-Equity Ratio
0.10 0.13 0.11 0.11 0.12
Debt-to-Capital Ratio
0.09 0.12 0.10 0.10 0.11
Long-Term Debt-to-Capital Ratio
0.06 0.09 0.07 0.02 0.07
Financial Leverage Ratio
1.34 1.34 1.36 1.33 1.35
Debt Service Coverage Ratio
1.09K 25.84 29.32 5.05 70.76
Interest Coverage Ratio
1.03K 1.03K 205.03 80.78 100.46
Debt to Market Cap
0.01 0.02 <0.01 <0.01 0.01
Interest Debt Per Share
4.45 5.77 4.22 4.28 4.38
Net Debt to EBITDA
-0.61 -0.52 -0.24 -0.65 -0.71
Profitability Margins
Gross Profit Margin
35.89%35.89%34.65%38.38%39.47%
EBIT Margin
19.67%19.49%20.34%23.95%23.83%
EBITDA Margin
25.25%23.54%25.71%28.60%28.01%
Operating Profit Margin
20.07%20.09%20.56%24.09%26.46%
Pretax Profit Margin
20.02%20.02%20.75%24.25%24.28%
Net Profit Margin
16.06%16.06%17.03%20.11%20.30%
Continuous Operations Profit Margin
16.06%16.06%17.03%20.11%20.30%
Net Income Per EBT
80.24%80.24%82.09%82.91%83.63%
EBT Per EBIT
99.74%99.66%100.94%100.68%91.76%
Return on Assets (ROA)
11.56%11.56%13.52%15.50%16.20%
Return on Equity (ROE)
16.68%15.54%18.37%20.60%21.82%
Return on Capital Employed (ROCE)
17.06%17.08%19.22%22.51%24.65%
Return on Invested Capital (ROIC)
13.61%13.62%15.69%17.81%20.49%
Return on Tangible Assets
11.89%11.89%13.97%16.01%16.78%
Earnings Yield
2.86%2.48%2.06%2.27%3.35%
Efficiency Ratios
Receivables Turnover
5.35 5.35 5.24 5.76 5.69
Payables Turnover
7.77 7.77 7.90 7.50 8.11
Inventory Turnover
4.44 4.44 5.01 4.18 4.21
Fixed Asset Turnover
1.67 0.00 1.72 1.95 2.29
Asset Turnover
0.72 0.72 0.79 0.77 0.80
Working Capital Turnover Ratio
2.45 2.66 2.57 2.21 2.26
Cash Conversion Cycle
103.44 103.44 96.30 101.93 105.85
Days of Sales Outstanding
68.21 68.21 69.71 63.33 64.18
Days of Inventory Outstanding
82.23 82.23 72.79 87.26 86.68
Days of Payables Outstanding
47.00 47.00 46.20 48.66 45.01
Operating Cycle
150.44 150.44 142.50 150.58 150.87
Cash Flow Ratios
Operating Cash Flow Per Share
10.44 10.44 8.95 10.45 9.73
Free Cash Flow Per Share
6.49 6.49 3.79 5.58 5.91
CapEx Per Share
3.95 3.95 5.16 4.87 3.83
Free Cash Flow to Operating Cash Flow
0.62 0.62 0.42 0.53 0.61
Dividend Paid and CapEx Coverage Ratio
2.17 2.17 1.50 1.85 2.14
Capital Expenditure Coverage Ratio
2.64 2.64 1.73 2.15 2.54
Operating Cash Flow Coverage Ratio
2.35 1.81 2.14 2.51 2.28
Operating Cash Flow to Sales Ratio
0.25 0.25 0.23 0.26 0.25
Free Cash Flow Yield
2.73%2.36%1.16%1.58%2.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
35.00 40.29 48.53 44.09 29.89
Price-to-Sales (P/S) Ratio
5.60 6.47 8.27 8.87 6.07
Price-to-Book (P/B) Ratio
5.44 6.26 8.91 9.08 6.52
Price-to-Free Cash Flow (P/FCF) Ratio
36.71 42.42 86.51 63.12 39.85
Price-to-Operating Cash Flow Ratio
22.89 26.35 36.60 33.69 24.19
Price-to-Earnings Growth (PEG) Ratio
59.41 34.00 -3.13 31.58 -2.61
Price-to-Fair Value
5.44 6.26 8.91 9.08 6.52
Enterprise Value Multiple
21.58 26.97 31.91 30.35 20.95
Enterprise Value
16.73B 19.52B 23.73B 25.62B 16.93B
EV to EBITDA
21.56 26.97 31.91 30.35 20.95
EV to Sales
5.44 6.35 8.20 8.68 5.87
EV to Free Cash Flow
35.67 41.63 85.86 61.80 38.54
EV to Operating Cash Flow
22.16 25.86 36.32 32.99 23.39
Tangible Book Value Per Share
42.30 42.30 35.14 37.11 34.40
Shareholders’ Equity Per Share
43.93 43.93 36.74 38.78 36.09
Tax and Other Ratios
Effective Tax Rate
0.20 0.20 0.18 0.17 0.16
Revenue Per Share
42.51 42.51 39.63 39.72 38.78
Net Income Per Share
6.83 6.83 6.75 7.99 7.88
Tax Burden
0.80 0.80 0.82 0.83 0.84
Interest Burden
1.02 1.03 1.02 1.01 1.02
Research & Development to Revenue
0.02 0.02 0.02 0.02 0.02
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.53 1.53 1.33 1.31 1.24
Currency in USD